On July 26, 2021, Jinhe Biotechnology CO., LTD. closed the transaction. The company amended the terms of the transaction. The company has now issued 145,132,743 shares at a price of CNY 5.65 per share for gross proceeds of CNY 819.99999795 million.

The registration procedures for the newly issued shares were completed at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch. The company announced that the transaction included participation from Inner-Mongolia JinHe Construction Installation Co., Ltd. for 35,398,230 shares and proceeds of CNY 199.99999950 million for 4.54% stake, Yihe Yinfeng Tianyuan (Tianjin) Group Co., Ltd. for 7,079,646 shares and proceeds of CNY 39.99999990 million for , Guotai Asset Management Co., Ltd. for 13,451,327 shares and proceeds of CNY 75.99999755 million and 1.72% stake, China Asset Management Co., Ltd. for 9,734,513 shares and proceeds of CNY 54.99999845 million and 1.25% stake, SAIC Qizhen (Shanghai) Asset Management Co., Ltd. for 7,079,646 shares and proceeds of CNY 39.99999990 million, China Galaxy Securities co., Ltd. for 23,716,814 shares and proceeds of CNY 133.99999910 million for 3.04% stake, Guosen Securities Co., Ltd. for 8,849,557 shares and proceeds of CNY 49.99999705 million for 1.13% stake, individual investor Zhuang Li for 12,389,380 shares and proceeds of CNY 69.99999700 million and 1.59% stake, Shanghai Bansheng Investment Management Co., Ltd. for 7,306,194 shares and proceeds of CNY 41.27999610 million, Caitong Fund Management Co., Ltd. for 20,127,436 shares and proceeds of CNY 113.72001340 million and 2.58% stake.